Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Lipids ; 28(5): 403-6, 1993 May.
Artigo em Inglês | MEDLINE | ID: mdl-8316047

RESUMO

Ether lipids are defined here as analogues of naturally occurring lysophosphatidylcholines with cytotoxic activity against neoplastic cells. The activity of 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine (ET18OMe) and 3-hexadecylmercapto-2-methoxymethyl-propyl-1-phosphocholine (Ilmofosine) (BM 41.440) was tested in variants of B16 murine melanoma, grown in adhesion cultures (B16F1 with low metastatic potential; B16F10 and B16BL6 with high metastatic potential). Cytotoxicity was evaluated by counting the cells that survived after 24 h of drug exposure. Cholesterol, sphingomyelin, total phospholipid and phosphatidylcholine levels were determined. After 24 h of drug exposure, cultures of the B16BL6 variant contained a larger number of cells, especially when high drug concentrations (100-250 microM) were used, than cultures of the B16F1 and B16F10 variants. The sensitivity to ET18OMe of the three variants was evaluated at different cell densities (at each density the dose was equalized per number of cells/well; 0.1 mumol/10(6) cells/well). In B16F1 and B16F10 cultures the dose-response curve was not affected by the number of cells/well, while in B16BL6 no more than 20% of the cells were killed at all cell densities measured. A linear relationship was noted between cell density and cholesterol/phospholipid and sphingomyelin/phosphatidylcholine ratios in the resistant variant B16BL6, confirming that lipid composition modulates the cytotoxic activity of ether lipids.


Assuntos
Antineoplásicos/farmacologia , Melanoma Experimental/patologia , Éteres Fosfolipídicos/farmacologia , Animais , Contagem de Células , Sobrevivência Celular/efeitos dos fármacos , Colesterol/metabolismo , Melanoma Experimental/tratamento farmacológico , Melanoma Experimental/metabolismo , Camundongos , Fosfatidilcolinas/metabolismo , Éteres Fosfolipídicos/uso terapêutico , Fosfolipídeos/metabolismo , Esfingomielinas/metabolismo , Células Tumorais Cultivadas
2.
Gastroenterol Clin North Am ; 16(3): 507-10, 1987 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-3436657

RESUMO

When paired data are considered and unpaired results are compared with controls, it appears that no significant changes of gastric histomorphology occur following biliopancreatic diversion.


Assuntos
Ácido Gástrico/metabolismo , Síndromes Pós-Gastrectomia/patologia , Estômago/cirurgia , Anastomose em-Y de Roux/efeitos adversos , Seguimentos , Gastrite Atrófica/etiologia , Humanos , Compostos Nitrosos/metabolismo , Obesidade/terapia , Células Parietais Gástricas/patologia , Estômago/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...